"Giant Cell Arteritis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)
| Descriptor ID |
D013700
|
| MeSH Number(s) |
C10.114.875.700 C10.228.140.300.850.500 C14.907.253.946.700 C14.907.940.090.530 C14.907.940.907.700 C17.800.862.252 C20.111.258.962.800
|
| Concept/Terms |
Giant Cell Arteritis- Giant Cell Arteritis
- Arteritides, Giant Cell
- Arteritis, Giant Cell
- Giant Cell Arteritides
- Arteritis, Giant Cell, Horton's
- Horton's Giant Cell Arteritis
- Horton Disease
- Horton Giant Cell Arteritis
- Horton's Disease
- Hortons Disease
- Arteritis, Giant Cell, Horton
- Giant Cell Arteritis, Horton
Temporal Arteritis- Temporal Arteritis
- Arteritides, Temporal
- Temporal Arteritides
- Arteritis, Temporal
Juvenile Temporal Arteritis- Juvenile Temporal Arteritis
- Arteritides, Juvenile Temporal
- Arteritis, Juvenile Temporal
- Juvenile Temporal Arteritides
- Temporal Arteritides, Juvenile
- Temporal Arteritis, Juvenile
Aortic Arteritis, Giant Cell- Aortic Arteritis, Giant Cell
- Giant Cell Aortitis, Horton's
- Giant Cell Aortitis
- Aortitis, Giant Cell
- Aortitides, Giant Cell
- Giant Cell Aortitides
- Giant Cell Aortic Arteritis
Cranial Arteritis- Cranial Arteritis
- Arteritides, Cranial
- Arteritis, Cranial
- Cranial Arteritides
|
Below are MeSH descriptors whose meaning is more general than "Giant Cell Arteritis".
Below are MeSH descriptors whose meaning is more specific than "Giant Cell Arteritis".
This graph shows the total number of publications written about "Giant Cell Arteritis" by people in this website by year, and whether "Giant Cell Arteritis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 22 | 0 | 22 |
| 2018 | 22 | 5 | 27 |
| 2019 | 11 | 3 | 14 |
| 2020 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Giant Cell Arteritis" by people in Profiles.
-
A Case of Post-COVID-19-Associated Paracentral Acute Middle Maculopathy and Giant Cell Arteritis-Like Vasculitis. J Neuroophthalmol. 2021 09 01; 41(3):351-355.
-
[Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis]. Med Clin (Barc). 2022 01 21; 158(2):91-92.
-
High incidence of giant cell arteritis during the COVID-19 pandemic: no causal relationship but possible involvement of stress. Clin Exp Rheumatol. 2021 Mar-Apr; 39 Suppl 129(2):199-200.
-
[Cough in times of coronavirus]. Z Rheumatol. 2021 Apr; 80(3):270-273.
-
Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Joint Bone Spine. 2021 05; 88(3):105150.
-
[SARS-CoV-2 infection triggering a giant cell arteritis]. Med Clin (Barc). 2021 03 12; 156(5):253-254.
-
Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review. J Rheumatol. 2021 07; 48(7):1053-1059.
-
Considerations for the Treatment of Inflammatory Neuro-Ophthalmologic Disorders During the COVID-19 Pandemic. J Neuroophthalmol. 2020 09; 40(3):305-314.
-
Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement. J Clin Rheumatol. 2020 Sep; 26(6):248-254.
-
Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis. Ann Rheum Dis. 2020 12; 79(12):1658-1659.